FY25 revenue consensus $86.89M. The raised revenue guidance represents a growth of approximately 33%-36% over the company’s prior year revenue.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBLL:
- Ceribell reports Q3 EPS (37c), consensus (41c)
- Ceribell files $300M mixed securities shelf
- Ceribell, Inc.: Strong Buy Rating Amid Market Potential and Clinical Advancements
- Ceribell’s Delirium Study: A New Frontier in EEG Technology
- Ceribell, Inc.: Innovative EEG System and Market Potential Drive Buy Rating